organophosphonates has been researched along with Weight Gain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, Y; Livingston, EG; Patel, K; Ransom, CE; Scott, GB; Siberry, GK; Watts, HD; Williams, P | 1 |
| Allen, PC; Bendele, R; Bennett, DR; Bischofberger, N; Brignolo, LL; Canfield, DR; Castillo, AB; Dearman, TG; Desjardins, J; Hamilton, M; Hirst, LL; Jerome, C; Marthas, ML; Martin, RB; Meyer, DJ; Pedersen, NC; Samii, VF; Spinner, A; Tarara, R; Valverde, C; Van Rompay, KK; Von Morgenland, W | 1 |
2 other study(ies) available for organophosphonates and Weight Gain
| Article | Year |
|---|---|
Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy.
Topics: Adenine; Adolescent; Anti-HIV Agents; Child Development; Female; Humans; Infant; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Weight Gain | 2013 |
Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques.
Topics: Absorptiometry, Photon; Adenine; Animals; Animals, Newborn; Anti-HIV Agents; Area Under Curve; Blood Chemical Analysis; Bone and Bones; Bone Density; Dose-Response Relationship, Drug; Fanconi Syndrome; Female; Glycosuria; Half-Life; Macaca mulatta; Male; Organophosphonates; Organophosphorus Compounds; Phosphorus; Tenofovir; Time Factors; Weight Gain | 2004 |